Agios Pharmaceuticals | AGIO - 贸易债权人



金融业
股票价格
USD
资产
USD 1.18B
现金及等价物
USD 113.6M
销售成本
USD 1.32M
流动资产
USD 834.84M
流动负债
USD 58.85M
债务
USD 40.21M
EBIT
USD -110.03M
EBITDA
USD -120.31M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.11B
销售毛利
USD 19.43M
债务利息支出
USD 1.18B
利息收入
USD 12.41M
贷款资金
USD 1.06M
市值
USD 2.2B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 18.8M
销售和管理费用
USD 38.46M
股票
USD 35.09M
贸易债权人
USD 13.75M
应收帐款人
USD 16.13M


贸易债权人 更改 日
AbbVie USD 3.59B 28.65B 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 6.59B 496M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Merck USD 3.86B 541M 2026-03
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03